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Abstract: 
Background and Objective: Povidone-iodine [polyvinylpyrrolidone-iodine complex (PVP-I)] is a broad-spectrum antimi-
crobial agent, frequently used in dentistry. In this study we investigated the short- and longterm effects on osteoblast 
number, viability, and function after short exposure to PVP-I with and without additional bone-morphogenetic protein-2 
(BMP-2). 
Material and Methods: Confluent osteoblast-like cell line (MC3T3-E1, subclone 24) cultures were exposed to pure PVP-I 
solution (7.7 mg/ml) and dilutions of 1:10, 1:100 and 1:1000 for 10 seconds and washed with phosphate buffer solution. 
Cell proliferation and viability was determined by MTT and differentiation status by alkaline phosphatase (ALP) activity 
6 days after initial plating.  In a separate experiment, long-term cell proliferation, viability and function were assessed 4 
weeks after PVP-I treatment by MTT and deposited calcium using an Alizarin-red staining test.  
Results: PVP-I decreased ALP activity substantially. Stimulation by BMP-2 recovered ALP activity to near control levels 
at 1:100 and 1:1000 dilutions of PVP-I. The MTT assay showed reduced proliferation of the preosteoblastic cells for all 
treatments, irrespective whether BMP-2 was used or not. Only at PVP-I dilutions of 1:1000 proliferation rate was back to 
normal levels (95.6±2.4 %). No adverse long-term effect of PVP-I on mineralization of the extracellular matrix (Alizarin-
red) for dilutions higher than 1:100 was observed. Interestingly, undiluted and 1:10 diluted PVP-I even showed a signifi-
cant increase in mineral deposition, especially in the presence of BMP-2.   
Conclusion: Short-time application of PVP-I in concentrations of 1:10 and higher lead to decreased viability and impaired 
differentiation. However, surviving cells showed good recovery and mineralization potential.  
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INTRODUCTION 
Periodontitis is a bacterial infection modified by systemic 
and environmental factors [1]. The main treatment is the 
effective reduction of supra- and subgingival pathogenic 
flora by mechanical means. A variety of antibiotics and anti-
septics have been introduced as adjunct to mechanical ther-
apy [2]. Whereas the use of antibiotics is warranted in certain 
cases, especially in patients with insufficient response to 
non-surgical therapy, it is associated with certain risks, nota-
bly the development of antibiotic resistance in various bacte-
rial species [3]. Administration of antimicrobial agents as a 
quick and inexpensive means of supporting mechanical 
periodontal debridement is worth consideration [4]. Antisep-
tic agents prevent or arrest the growth or action of microor-
ganisms. They have a considerably broader spectrum of ac-  
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tivity than antibiotics and, in contrast to antibiotics, often 
aim at multiple intracellular targets, which reduce the likeli-
hood of resistance development [4]. However, since antisep-
tics, unlike antibiotics, are potentially toxic to both infectious 
and host cells, their application in humans is limited to in-
fected wounds, skin and mucosa. Povidone–iodine [poly-
vinylpyrrolidone–iodine complex (PVP-I)] is an iodofor with 
a broad spectrum and high antimicrobial activity, low po-
tency for developing resistance and adverse reactions, and 
low financial cost [5]. In the oral cavity it is used at dilution 
levels of 1 to 10% in several conditions and its utility has 
also been reported in non-surgical periodontal therapy [4-7]. 
Like other antiseptics, PVP-I has a non-selective mechanism 
of action, and the high concentrations used in the oral cavity 
may eventually adversely affect the host cells. In vitro stud-
ies have reported deleterious effects on fibroblasts and os-
teoblasts [8, 9]. A recent in vitro study by Cabral & Fernan-
des [9] using osteoblastic human alveolar bone cells has 
shown that 5 and 10% PVP-I caused cell death within min-
utes; contact with 1% PVP-I resulted in a loss of the charac-
teristic elongated cell shape.  PVP-Iodine and Osteoblasts  The Open Dentistry Journal, 2009, Volume 3    209 
The aim of the present study was to investigate short- and 
long-term effects on preosteoblastic cells and maintenance of 
their osteoblastic lineage by BMP-2 application following a 
10 second exposure to PVP-I which mimics the clinical 
situation during periodontal interventions. 
MATERIAL AND METHODOLOGY 
We have chosen murine MC3T3-E1 cells, since os-
teoblastic cells are exposed to PVP-I during periodontal in-
terventions. MC3T3-E1 cells represent a well characterized 
cell line of the osteoblastic lineage which undergoes all 
stages of differentiation from preosteoblasts to mature os-
teoblasts in vitro. MC3T3 secrete bone morphogenetic pro-
teins (BMP) and differentiate by the action of BMP to ma-
ture osteoblasts. An accelerated differentiation towards ma-
ture osteoblasts can be induced by exposure to additional 
BMP-2 and can be monitored by an increase in alkaline 
phosphatase (ALP) activity. ALP activity is an early marker 
for osteoblast maturation. The cellular activity of mature 
osteoblasts is characterized by the mineralization of their 
extracellular matrix. Therefore, mineralization is a late 
marker for osteoblast maturation. Quantification of matrix 
mineralization can be performed by the dye Alizarin red 
which stains deposited calcium.   
Activity of mitochondrial dehydrogenases (MTT-test) 
substituting for the radioactivity based tritiated thymidine 
incorporation assay was used to determine cellular activity 
and proliferation. Live/dead staining was used to identify 
living cells based on their ability to convert a calcein deriva-
tive into its fluorescent equivalent which is mediated by in-
tracellular esterase enzyme activity. Dead cells are detected 
by ethidium bromide, since only in leaky cells the DNA is 
exposed allowing ethidium bromide binding.  
Cell Line, Culture Technique and Alkaline Phosphatase 
Determination 
MC3T3-E1 cells of passage below 20 were supplied by 
ECACC (Porton Down, Salisbury; Great Britain) and grown 
in an alpha-modified Minimum Essential Medium (Invitro-
gen/Gibco) containing 10 % fetal calf serum, 50g/ml 
penicillin/streptavidin, and 50 g/ml ascorbic acid. For BMP 
treatment, the culture medium was supplemented with 1 
g/ml rhBMP-2. To examine the biological effect of antisep-
tics, 1x10
5 cells were plated in each well of 6-well plates and 
grown to confluency for 2 days. On day 3 the cell culture 
medium was aspirated and 1 ml antiseptic (PVP-iodine, B. 
Braun Medical AG, Switzerland) added, either undiluted 
(7.7, mg/ml) or diluted volume/volume (1:10, 1:100 and 
1:1000) in phosphate buffered saline (PBS). Chlorhexidine 
(CHX) at a concentration of 0.2% (Kantonsapotheke, Zürich, 
Switzerland) was used as a control agent. After an exposure 
time of 10 seconds, the respective antiseptic solution was 
aspirated and the cells washed twice with 4 ml of PBS to 
remove all residual antiseptics, before 4 ml of culture me-
dium were added. Medium exchange was performed on day 
4 and alkaline phosphatase (ALP) determined on day 6. The 
cells were washed 3 times with phosphate buffered saline, 
and the cells from a single well were combined in 0.5 ml of 
lysis buffer (0.56 M 2-amino-2-methyl-propane-1-ol pH 10), 
and homogenized using an omni-mixer. 200 l of the cell 
lysate were mixed with 200 l of lysis buffer supplemented 
with 20 mM p-nitrophenylphosphate, and 4 mM MgCl2 at 
4°C, allowing the determination of ALP activity. ALP activ-
ity was normalized to total protein and expressed as nmol 
nitrophenylate generated per min per mg protein.  
Cell Proliferation  
MC3T3 cell proliferation was assessed using the thia-
zolyl blue tetrazolium (MTT; SigmaAldrich) dye reduction 
assay.  Briefly, MC3T3 cells were grown in 6 well plates as 
described for ALP activity measurements. At selected time 
points, MTT (500μl; 5mg/ml in phosphate buffered saline) 
was added to each well and incubated for 4 hours at 37°C in 
the dark.  Following incubation, MTT was aspirated from 
each well and MTT-formazan crystals were solubilised by 
the addition of isopropanol (200μl; 1N HCl).  Absorbance of 
each well was then measured at 570 nm. 
Calcium Deposition by Preosteoblastic Cells 
MC3T3-E1 cells were plated at a density of 30,000 
cells/cm
2 in 6 well plates. Exposure to antiseptics was per-
formed as described earlier. From day 3 on the culture me-
dium was supplemented with 50 g/ ml ascorbic acid and 10 
mM -glycerophosphate. Medium was changed once a week 
and calcium deposition determined 4 weeks after the expo-
sure of the cells to the antiseptics. For Alizarin red staining 
of calcium, culture cells were washed once with phosphate 
buffered saline and fixed for 1 hour in 70% ethyl alcohol. 
After rinsing the cells with water, 1 ml of an Alizarin red 
solution (40 mM, pH 4.2) was added, and the cells were 
stained for 10 minutes. Non-specific staining was removed 
by 5 washes with water and 15 minutes incubation in PBS, 
before the stained wells were photographed. For quantiza-
tion, cells stained with Alizarin red were destained with 10% 
cetylpyridinium chloride in 10 mM sodium phosphate, pH 
7.0. Calcium complexed by Alizarin red was determined in 
the distaining solution at OD562 and the amount of calcium 
calculated according to a standard calcium curve respec-
tively. 
Cell Live/Dead Staining: (Calcein AM/Ethidium Bromide 
(EtBr) 
The live/dead staining is based on Calcein AM, a sub-
strate which is converted intracellularely into fluorescent 
calcein by intracellular esterases, only retained in cells with 
an intact plasma membrane. Ethidium bromide is a fluores-
cent nucleic acid stain that is only able to pass through dis-
rupted nuclear membranes of dead cells. Briefly, for the 
live/dead discrimination, the cell medium was supplemented 
with calcein (5 M). Following an incubation of 30 minutes, 
the supernatant was aspirated and the cells washed once with 
Tris-buffered saline (TBS; 10 mM Tris; 150 mM NaCl, pH 
7.4). Next, the cells were exposed to EtBr (10 g/ml in TBS) 
for 2 minutes at RT followed by two washes with TBS 
whereupon an inspection under the fluorescence microscope 
was performed. Calcium fluorescence was determined at 
ex=496 nm and em=516 nm, and assessed using a FITC 
filter. EtBr was analysed at ex=518 nm and em=605 nm, 
using a rhodamine filter. 
Statistical Analysis 
Student's t-test was implemented by a commercially 
available software package (SSPE, Chicago, Il). All values 210    The Open Dentistry Journal, 2009, Volume 3  Schmidlin et al. 
are represented as means ± standard deviations of at least 2 
independent experiments, each performed in triplicates. 
P<0.01, indicated by ** was set for statistical significant 
differences. 
RESULTS 
The short-term effect of PVP-I determined by changes in 
ALP activity showed that a 10 second exposure to PVP-I 
decreased ALP activity substantially (Fig. 1A). Even 1:1000 
dilutions of PVP-I lowered ALP activity to 63.5±10.2 % 
(P<0.01, N=6) of untreated cells indicating a dedifferentia-
tion effect of PVP-I on preosteoblastic cells. Exposure of 
preosteoblasts treated with 1:100 dilutions of PVP-I to the 
differentiation factor BMP-2 recovered ALP-activity to near 
control levels (98.6±5.0 %). At 1:1000 dilutions of PVP-I 
BMP-2 exposure increased ALP activity above control levels 
(111.6±12.2 %) although this increase was not statistically 
significant. These results suggest that PVP-I exposure retards 
the differentiation of osteoblasts as seen by the reduction in 
ALP activity without blocking the susceptibility of the 
preosteoblasts to the differentiation factor BMP-2.  
The MTT assay was used to determine proliferation rate 
of the preosteoblasts. As shown in Fig. (1B), all treatments 
with the exception of the PVP-I dilution 1:1000, including 
exposure to BMP-2, reduced the proliferation of the 
preosteoblastic cells. At PVP-I dilutions of 1:1000, prolifera-
tion rate was back to normal levels (95.6±2.4 %) although 
ALP activity was still much lower than in the control cells 
(Fig. 1A). Thus, preosteoblastic cells exposed to 1:1000 dilu-
tion of PVP-I show a decrease in their differentiation status 
in the short-term despite the fact that proliferation rate had 
recovered to normal levels. When the differentiation factor 
BMP-2 is added, however, ALP activity recovered to normal 
levels already at 10 fold higher PVP-I concentrations. There-
fore, preosteoblastic cells exposed to PVP-I, even if diluted 
1:1000 have partially lost their osteogenic differentiation 
level but maintain their susceptibility to osteogenic signals 
like BMP-2.  
The long-term effect of PVP-I on mineralization of the 
extracellular matrix was assessed by alizarin-red binding to 
calcium depositions. Mineralization determined 4 weeks 
after the exposure to PVP-I was normal for dilutions 1:100 
and higher (Fig. 2A). Therefore, exposure of preosteoblasts 
to PVP-I dilutions 1:100 and higher seems to have no nega-
tive effect on the maturation of preosteoblasts to osteoblasts 
in the long-term, both for untreated and BMP-2 treated cells. 
Interestingly, undiluted and 1:10 diluted PVP-I showed a 
significant increase in mineral deposition (Fig. 2A) suggest-
ing that a certain level of cellular activity survives even this 
harsh treatment. The CHX-0.2% treated cells with BMP 
could not be evaluated because the cells and their extracellu-
lar matrix always detached over the period of 4 weeks. 
To further assess this finding live/dead staining was per-
formed in preosteoblastic cells exposed to PVP-I pure and 
1:10 PVP-I dilutions and compared to untreated cells. 4 
weeks after exposure of preosteoblastic cells to PVP-I, fluo-
rescent calcein signal indicative for living cells is present in 
all samples although to a much lower extent than in the un-
treated control sample (Fig. 2B). Therefore, a minor fraction 
of the cells survive a short 10 second long exposure to 1:10 
diluted PVP-I and pure PVP-I since they maintain an intact 
cell membrane enclosing active esterases necessary for a 
positive readout for fluorescent calcein detection.  This mi-
nor fraction of cells could potentially be responsible for the 
more intense mineralization of the matrix, suggesting that 
these cells have a higher mineralization potential than un-
treated cells. 
DISCUSSION 
This study assessed the short- and long-term effects on 
osteoblast proliferation, viability, and function after short 
exposure to PVP-I. The existing literature concerning this 
topic is scarce, especially when focusing on dental tissues. 
Two studies have demonstrated that PVP-iodine is cytotoxic 
to dental tissue, i.e. fibroblasts and osteoblasts [8, 9]. In ac-
cordance to these data, we found a significant decline in cell 
proliferation and ALP activity after short-time application of 
higher PVP-iodine concentrations (up to 1/10) but we also 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Short term effect of PVP-I treatment on ALP activity and 
proliferation. Preosteoblastic cells were exposed to different con-
centrations of PVP-I on day 2 after seeding and ALP activity was 
determined on day 6. (A) ALP activity without exposing MC3T3-
E1 cells to 1 g/ml BMP-2 was significantly reduced compared to 
the control even beyond PVP-I dilutions of 1:1000 (**). In case that 
MC3T3-cells were stimulated by the osteogenic differentiation 
factor BMP-2, a significant (**) decrease in ALP activity below the 
control level was only observed in cells exposed to PVP-I dilutions 
of 1:10 or below. (B) MTT test revealed that only dilutions of PVP-
I up to 1:100 reduced proliferation rates significantly below the 
control level, irrespective of exposure to BMP-2 (**) or not (**).  
** indicates P values of a simple t-test below 0.01 when compared 
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found effects on the differentiation status of preosteoblasts, 
an aspect, which had been overlooked so far.  
The results of the present study suggest that PVP-I in 
concentrations of 1:10 and higher lead to decreased viability 
and loss of differentiation towards the osteogenic lineage 
although these cells were already determined to become ma-
ture osteoblasts. The application of BMP-2 can overcome 
this loss of determination and redirect these cells towards the 
osteoblastic lineage (Fig. 1A). Since preosteoblasts deposit 
autologous BMP in the extracellular matrix one could specu-
late that PVP-I treatment reduces the osteogenic cues already 
deposited into the extracellular matrix by inactivating 
autologous BMP. Therefore, a therapeutic application of 
BMPs or other bone formation stimulating agents following 
PVP-I treatment may be an appropriate approach, which 
merits further investigation.  
In the long-term, however, preosteoblasts exposed to 
PVP-I will recover and mature to osteoblasts even without 
addition of BMP since the cells will continue to deposit os-
teogenic cues into the newly formed extracellular matrix 
(Fig. 2A). Prerequisite would be that osteogenic cells will 
repopulate disinfected areas. If not, osteogenic cues like 
BMP-2 should be added to the extracellular matrix of the 
disinfected and washed area.  
This transient effect on the differentiation let this antisep-
tic to appear as a considerable alternative for other effective 
disinfection normally applied during periodontal surgery. 
Further clinical studies are, however, needed to clear these 
aspects. In this context it is important to mention that the 
clinical situation greatly differs from the laboratory model. 
Data concerning the penetration of antiseptic agents into 
these vital tissues is scarce and the real concentrations during 
application under clinical conditions can only be estimated. 
Studies used different concentrations ranging from 0.1 % to 
10 % [10-12], but no mandatory recommendations are given 
in literature so far. Laboratory conditions cannot be directly 
transferred to the situation of the bacterial biofilm in perio-
dontal pockets in vivo. In the clinical situation, dilution of 
the antimicrobial agent must be anticipated due to bleeding 
caused by mechanical instrumentation and due to concomi-
tant rinsing. Several inactivating reactive substances of the 
blood and serum may additionally reduce the substantivity of 
iodine. This might explain that albeit cytotoxic effects in 
vitro, wound healing in vivo is less affected [13]. In addition, 
reparative and regenerative periodontal processes are guided 
by the surrounding tissues, namely epithelium, connective 
tissue, periodontal ligament and bone which act as a source 
of growth factors and cells. Both will substitute for loss of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Long-term effect of PVP-I treatment on preosteoblastic cells. Preosteoblastic cells were exposed to different concentrations of PVP-
I on day 2 after seeding and evaluated 4 weeks later. (A) Alizarin-red staining method was used to determine mineral deposition. Dilutions of 
PVP-I of 1:100 and higher had no effect on the calcium deposition into the extracellular matrix. Exposure to undiluted or 1:10 diluted solu-
tions of PVP-I, however, increased mineral deposition compared to the control untreated or respective BMP treated sample significantly (**) 
(**). (B) Live/dead staining revealed the presence of a majority of calcein stained living cells and a minority of EtBr stained dead cells in 
control samples. Although to a much lower extend living cells were also detected in samples treated with pure PVP-I or 1:10 dilutions. This 
minor fraction of surviving cells could account for the extended mineral deposition detected in the respective samples.   212    The Open Dentistry Journal, 2009, Volume 3  Schmidlin et al. 
cells in the treated area but also redirect surviving cells into 
the appropriate lineage.  
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